Cargando…

N(6)-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development

N(6)-Methyladenosine (m(6)A) modification is the most pervasive modification of human mRNA molecules. It is reversible via regulation of m(6)A modification methyltransferase, demethylase and proteins that preferentially recognize m(6)A modification as “writers”, “erasers” and “readers”, respectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Yi, Wan, Arabella, Lin, Ziyou, Lu, Xiongbin, Wan, Guohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251950/ https://www.ncbi.nlm.nih.gov/pubmed/30505654 http://dx.doi.org/10.1016/j.apsb.2018.06.001

Ejemplares similares

RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
por: Niu, Yi, et al.
Publicado: (2019)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers
por: Li, Qinghai, et al.
Publicado: (2021)

Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)

Multifaceted Functions and Novel Insight Into the Regulatory Role of RNA N(6)-Methyladenosine Modification in Musculoskeletal Disorders
por: Zhang, Wenchao, et al.
Publicado: (2020)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
por: Zhang, Yi, et al.
Publicado: (2023)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

Evolution of transcript modification by N(6)-methyladenosine in primates
por: Ma, Lijia, et al.
Publicado: (2017)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Epigenetic regulation of N6‐methyladenosine modifications in obesity
por: Sun, Mingli, et al.
Publicado: (2021)

Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

Corrigendum to “Function of N6-Methyladenosine Modification in Tumors”
por: Zhang, Nan, et al.
Publicado: (2023)

Mechanism of RNA modification N6-methyladenosine in human cancer
por: Zhou, Zijian, et al.
Publicado: (2020)

Novel insights into the interaction between N6-methyladenosine modification and circular RNA
por: Xu, Tao, et al.
Publicado: (2022)

Mechanisms of N6-methyladenosine modification in tumor development and potential therapeutic strategies (Review)
por: Pu, Xi, et al.
Publicado: (2023)

Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
por: Shu, Liqi, et al.
Publicado: (2021)

N6-Methyladenosine Modification and Its Regulation of Respiratory Viruses
por: Feng, Qianyu, et al.
Publicado: (2021)

Role of N(6)-Methyladenosine RNA Modification in Cardiovascular Disease
por: Song, Dandan, et al.
Publicado: (2021)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
por: Zhang, Ze, et al.
Publicado: (2022)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

Roles of N(6)-methyladenosine (m(6)A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
por: Chen, Jiahua, et al.
Publicado: (2022)

Structural Insights into N(6)-methyladenosine (m(6)A) Modification in the Transcriptome
por: Huang, Jinbo, et al.
Publicado: (2018)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity
por: Zheng, Siyi, et al.
Publicado: (2022)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
por: He, Cheng, et al.
Publicado: (2023)

Novel Insights into The Roles of N(6)-methyladenosine (m(6)A) Modification and Autophagy in Human Diseases
por: Liang, Jiaxin, et al.
Publicado: (2023)

Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia
por: Niu, Yi, et al.
Publicado: (2021)

N6-Methyladenosine RNA Modification Landscape in the Occurrence and Recurrence of Nasopharyngeal Carcinoma
por: Wang, Yu Min, et al.
Publicado: (2022)

The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development
por: Liu, Shougeng, et al.
Publicado: (2022)

RNA N(6)-methyladenosine modification in cancers: current status and perspectives
por: Deng, Xiaolan, et al.
Publicado: (2018)

Transcriptome-wide reprogramming of N(6)-methyladenosine modification by the mouse microbiome
por: Wang, Xiaoyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dcn8h1t29s1ubi95vacu061plr